Refer KDT 6/e p 741 *Rifamipicin is a powerful enzyme inducer. It increases the metabolism of protease inhibitors and thus decreases the efficacy of anti retroviral therapy *another drug, rifabutin is devoid of these interactions and is the preferred agent for treatment of mycobacterial infections in patients